Pharmacological Treatement Used in the Management of Overactive Bladder

Abstract

In 2002, the International Continence Society defined overactive bladder (OAB) as a clinical condition that implies urinary urgency with or without urge incontinence, regularly associated with frequent urination and nocturia. The aim of the study was to realize an update for clinicians that are managing overactive bladder, with an overview of the current management and also the future perspectives of the therapies used for this disease, including pharmacology, tolerability, side effects, and efficacy. Although anticholinergic drugs will continue to be the gold standard for the pharmacological treatment of overactive bladder, their side effects and limitations urge the necessity of novel drugs.